Latest filing published 12 Feb 2018 for Hemogenyx Pharmaceuticals PLC, €4,773.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Adrian Beeston: trading record in brief
Adrian Beeston is a declared insider of Hemogenyx Pharmaceuticals PLC, with filings sourced from RNS (LSE). Between 6 October 2017 and 9 February 2018, the trades on record add up to 3 filings.
The open-market record is one-sided, with 3 purchases worth €18k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2018 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €4,773. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
On 12 February 2018 came the latest disclosure, an open-market purchase for €4,773 in Hemogenyx Pharmaceuticals PLC. Between a trade and the moment it shows up on RNS (LSE), the median delay is 4 days. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Adrian Beeston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200,000 shares@ £0.02126.0% of flowLondon Stock ExchangeISIN GB00BYX3WZ24FCA-NSM:LSE20180212070005_13528927_20200330111413354_17975Canonical exit: 10 May 2018 (T+90)
- 400,000 shares@ £0.029672.1% of flowLondon Stock ExchangeISIN GB00BYX3WZ24FCA-NSM:LSE20171011070004_13392501_20200330131537664_7159Canonical exit: 4 Jan 2018 (T+90)
- 10,000 shares@ £0.0311.9% of flowLondon Stock ExchangeISIN GB00BYX3WZ24FCA-NSM:LSE20171010070004_13391128_20200330131537618_6138-0Canonical exit: 4 Jan 2018 (T+90)
3 of 3 declarations